Published

Onesource Specialty Pharma completes fundraising of $ 95 mn - Express Pharma

Summary by Express Pharma
OneSource Specialty Pharma, an associate company of Strides, secured an equity commitment of $ 95 million from marquee investors at a pre-money equity valuation of $ 1.65 billion.  The fundraising was led by HBM Healthcare Investments and associated investors, with additional participation inter alia from WhiteOak Capital, Param Capital, Motilal Oswal, Enam Holdings, SBI Life Insurance and Valuequest Investment Advisors. OneSource has completed …
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)